WeightWatchers enters weight loss drug market with acquisition
The weight-loss programs provider is partnering with a telemedicine company that prescribes the class of drugs that can aid weight reduction, like Novo Nordisk’s Wegovy and Eli Lilly’s Mounjaro.
By Emma Court, bloomberg
WW International Inc. looked at more than 30 different startups that prescribe obesity medications before acquiring the telemedicine company Sequence last month, Chief Executive Officer Sima Sistani said.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Eli Lilly's Mounjaro could overtake Wegovy, says professor
For subscribers
